Ascendis Pharma A/S - American Depositary Shares — Cash Flow (NASDAQ:ASND) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities —————— — Cash from investing activities —————— — Cash from financing activities —————— — Free cash flow —————— —

Haberler

FDA, Ascendis’in haftada bir kez uygulanan akondroplazi tedavisini onayladı

FDA approves Ascendis’ once-weekly achondroplasia treatment

Ascendis Pharma yıllık toplantı tarihini açıkladı ve 2025 raporlarını yayımladı

Ascendis Pharma schedules annual meeting and releases 2025 reports

RBC Capital, Ascendis Pharma hissesi için tavsiyesini korudu

RBC Capital reiterates Ascendis Pharma stock rating on Yorvipath momentum

Cantor Fitzgerald, Ascendis Pharma’nın hisse fiyat hedefini CNP franchise görünümü nedeniyle 300 dolara yükseltti

Cantor Fitzgerald raises Ascendis Pharma stock price target to $300 on CNP franchise outlook

Stifel, Yorvipath büyümesi nedeniyle Ascendis Pharma hisse fiyat hedefini 325 dolara yükseltti

Stifel raises Ascendis Pharma stock price target to $325 on Yorvipath growth

Baird maintains BioMarin stock rating amid competitor’s positive trial data

BioMarin, Ascendis stocks fall after BridgeBio’s positive achondroplasia data